49 related articles for article (PubMed ID: 18793612)
1. Down syndrome critical region 2 protein inhibits the transcriptional activity of peroxisome proliferator-activated receptor beta in HEK293 cells.
Song HJ; Park J; Seo SR; Kim J; Paik SR; Chung KC
Biochem Biophys Res Commun; 2008 Nov; 376(3):478-82. PubMed ID: 18793612
[TBL] [Abstract][Full Text] [Related]
2. DSCR2, a Down syndrome critical region protein, is localized to the endoplasmic reticulum of mammalian cells.
Possik PA; Sommer CA; Issa Hori J; Machado-Santelli GM; Jamur MC; Henrique-Silva F
Eur J Histochem; 2004; 48(3):267-72. PubMed ID: 15590417
[TBL] [Abstract][Full Text] [Related]
3. Molecular and cellular characterization of the Down syndrome critical region protein 2.
Vesa J; Brown Y; Greenfield D; Korenberg JR
Biochem Biophys Res Commun; 2005 Mar; 328(1):235-42. PubMed ID: 15670775
[TBL] [Abstract][Full Text] [Related]
4. Down syndrome critical region gene 2: expression during mouse development and in human cell lines indicates a function related to cell proliferation.
Vidal-Taboada JM; Lu A; Pique M; Pons G; Gil J; Oliva R
Biochem Biophys Res Commun; 2000 May; 272(1):156-63. PubMed ID: 10872820
[TBL] [Abstract][Full Text] [Related]
5. The ribosomal protein rpL11 associates with and inhibits the transcriptional activity of peroxisome proliferator-activated receptor-alpha.
Gray JP; Davis JW; Gopinathan L; Leas TL; Nugent CA; Vanden Heuvel JP
Toxicol Sci; 2006 Feb; 89(2):535-46. PubMed ID: 16280383
[TBL] [Abstract][Full Text] [Related]
6. Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity.
Sumanasekera WK; Tien ES; Davis JW; Turpey R; Perdew GH; Vanden Heuvel JP
Biochemistry; 2003 Sep; 42(36):10726-35. PubMed ID: 12962497
[TBL] [Abstract][Full Text] [Related]
7. The role of peroxisome proliferator-activated receptor-beta/delta in epidermal growth factor-induced HaCaT cell proliferation.
Liang P; Jiang B; Yang X; Xiao X; Huang X; Long J; Zhang P; Zhang M; Xiao M; Xie T; Huang X
Exp Cell Res; 2008 Oct; 314(17):3142-51. PubMed ID: 18625220
[TBL] [Abstract][Full Text] [Related]
8. Ligand-mediated regulation of peroxisome proliferator-activated receptor (PPAR) beta/delta: a comparative analysis of PPAR-selective agonists and all-trans retinoic acid.
Rieck M; Meissner W; Ries S; Müller-Brüsselbach S; Müller R
Mol Pharmacol; 2008 Nov; 74(5):1269-77. PubMed ID: 18701617
[TBL] [Abstract][Full Text] [Related]
9. Three members of the human pyruvate dehydrogenase kinase gene family are direct targets of the peroxisome proliferator-activated receptor beta/delta.
Degenhardt T; Saramäki A; Malinen M; Rieck M; Väisänen S; Huotari A; Herzig KH; Müller R; Carlberg C
J Mol Biol; 2007 Sep; 372(2):341-55. PubMed ID: 17669420
[TBL] [Abstract][Full Text] [Related]
10. [Role of peroxisome proliferator-activated receptor beta in the inhibitory effect of epidermal growth factor on apoptosis of HaCaT].
ZHOU J; LIANG PF; JIANG BM; HUANG XY
Zhonghua Shao Shang Za Zhi; 2009 Aug; 25(4):294-7. PubMed ID: 19951549
[TBL] [Abstract][Full Text] [Related]
11. Role of ceramide kinase in peroxisome proliferator-activated receptor beta-induced cell survival of mouse keratinocytes.
Tsuji K; Mitsutake S; Yokose U; Sugiura M; Kohama T; Igarashi Y
FEBS J; 2008 Aug; 275(15):3815-26. PubMed ID: 18565104
[TBL] [Abstract][Full Text] [Related]
12. Expression level and agonist-binding affect the turnover, ubiquitination and complex formation of peroxisome proliferator activated receptor beta.
Rieck M; Wedeken L; Müller-Brüsselbach S; Meissner W; Müller R
FEBS J; 2007 Oct; 274(19):5068-76. PubMed ID: 17803688
[TBL] [Abstract][Full Text] [Related]
13. The peroxisome proliferator-activated receptor β/δ (PPARβ/δ) agonist GW501516 prevents TNF-α-induced NF-κB activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.
Barroso E; Eyre E; Palomer X; Vázquez-Carrera M
Biochem Pharmacol; 2011 Feb; 81(4):534-43. PubMed ID: 21146504
[TBL] [Abstract][Full Text] [Related]
14. Development of improved PPARβ/δ inhibitors.
Toth PM; Naruhn S; Pape VF; Dörr SM; Klebe G; Müller R; Diederich WE
ChemMedChem; 2012 Jan; 7(1):159-70. PubMed ID: 22025402
[TBL] [Abstract][Full Text] [Related]
15. (Z)-2-(2-bromophenyl)-3-{[4-(1-methyl-piperazine)amino]phenyl}acrylonitrile (DG172): an orally bioavailable PPARβ/δ-selective ligand with inverse agonistic properties.
Lieber S; Scheer F; Meissner W; Naruhn S; Adhikary T; Müller-Brüsselbach S; Diederich WE; Müller R
J Med Chem; 2012 Mar; 55(6):2858-68. PubMed ID: 22369181
[TBL] [Abstract][Full Text] [Related]
16. Multiple peroxisome proliferator-activated receptor beta subtypes from Atlantic salmon (Salmo salar).
Leaver MJ; Ezaz MT; Fontagne S; Tocher DR; Boukouvala E; Krey G
J Mol Endocrinol; 2007 Mar; 38(3):391-400. PubMed ID: 17339402
[TBL] [Abstract][Full Text] [Related]
17. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.
Piqueras L; Reynolds AR; Hodivala-Dilke KM; Alfranca A; Redondo JM; Hatae T; Tanabe T; Warner TD; Bishop-Bailey D
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):63-9. PubMed ID: 17068288
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) acts as regulator of metabolism linked to multiple cellular functions.
Wagner KD; Wagner N
Pharmacol Ther; 2010 Mar; 125(3):423-35. PubMed ID: 20026355
[TBL] [Abstract][Full Text] [Related]
19. Fast skeletal muscle troponin I is a co-activator of estrogen receptor-related receptor alpha.
Li Y; Chen B; Chen J; Lou G; Chen S; Zhou D
Biochem Biophys Res Commun; 2008 May; 369(4):1034-40. PubMed ID: 18331830
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor beta/delta activation inhibits hypertrophy in neonatal rat cardiomyocytes.
Planavila A; Rodríguez-Calvo R; Jové M; Michalik L; Wahli W; Laguna JC; Vázquez-Carrera M
Cardiovasc Res; 2005 Mar; 65(4):832-41. PubMed ID: 15721863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
